Factors associated with persistent airflow limitation in severe asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 5, 2001, Pages 744-748

  Ten Brinke, Anneke ^a   Zwinderman, Aeilko H ^b   Sterk, Peter J ^b   Rabe, Klaus F ^b   Bel, Elisabeth H ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Airway obstruction; Asthma; Eosinophilia; Severity of illness index; Sputum

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; HISTAMINE; IMMUNOGLOBULIN E; NITRIC OXIDE; PREDNISONE;

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATOPY; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUTROPHILIA; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; RISK FACTOR; SMOKING;

EID: 0035447569     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.5.2011026     Document Type: Article

References (42)

1. Asthma and irreversible airflow obstruction
2. A 15-year follow-up study of ventilatory function in adults with asthma
3. Rate of decline of lung function in subjects with asthma
4. A 10-year follow-up of 180 adults with bronchial asthma: Factors important for the decline in lung function
5. Difficult asthma
6. Consequences of long-term inflammation. Airway remodeling
7. Persistent peripheral airway obstruction in children with severe asthma
8. Peripheral airways obstruction on high-resolution computed tomography in chronic severe asthma
9. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease
10. Natural history of chronic asthma and its long-term effects on pulmonary function
11. Outcome of asthma: Longitudinal changes in lung function
12. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: A 30-year follow-up study
13. Skin test reactivity to common aeroallergens and decline of lung function: The Normative Aging Study
14. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample
15. Decline of lung function in adults with bronchial asthma
16. Consequences of long-term inflammation: The natural history of asthma
17. Blood eosinophilia and FEV1: Cross-sectional and longitudinal analyses
18. Eosinophils and pulmonary function: An epidemiologic study of adolescents and young adults
19. Difficult/therapy-resistant asthma: The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies
20. Lung volumes and forced ventilatory flows
21. Airway responsiveness: Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
22. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease
23. Standardization of the measurement of transfer factor (diffusing capacity)
24. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects
25. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma
26. Feasibility of sputum induction in patients with severe asthma
27. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials: Influence of clinical diagnosis, spirometric, and anthropometric variables
28. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students
29. Exhaled nitric oxide measurements in a population sample of young adults
30. Induced sputum cell counts in healthy adults
31. Nonreversible airflow obstruction in life-long non-smokers with moderate to severe asthma
32. A working classification of asthma
33. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1
34. Baseline airway hyperresponsiveness and its reversible component: Role of airway inflammation and airway calibre
35. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
36. Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts
37. Eosinophils adhere to and stimulate replication of lung fibroblasts in vitro
38. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma
39. Eosinophilic inflammation in asthma
40. Inflammation of small airways in asthma
41. Increased glucocorticoid receptor-beta in airway cells of glucocorticoid-insensitive asthma
42. Eosinophilic airway inflammation in nasal polyposis